Omnipaque

Product manufactured by Ge Healthcare Inc.

Application Nr Approved Date Route Status External Links
NDA020608 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage—intrathecal Omnipaque 300 Is Indicated For Intrathecal Administration In Adults Including Myelography (Lumbar, Thoracic, Cervical, Total Columnar) And In Contrast Enhancement For Computerized Tomography (Myelography, Cisternography, Ventriculography).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Iohexol IOHEXOL ZINC3830945

Comments